Sequencing an individual patient’s genome is no longer cost prohibitive. Physicians can use this information to develop custom-tailored treatments that have shown efficacy in other patients with similar genetic characteristics. This is the basis of precision medicine and in late February of 2016 the White House held a summit to promote continued research in this field.
Click here to read more about the White House’s Precision Medicine Initiative.
Marylyn Ritchie, PhD
Senior Investigator & Founding Director: Biomedical & Translational Informatics Program
Geisinger Health System
